Navigation Links
Reportlinker Adds Proteomics - Technologies, Markets and Companies
Date:9/7/2010

of proteomic companies and research281

Technical advances in proteomics281

Changing trends in healthcare in future282

Challenges facing proteomics282

Magnitude and complexity of the task282

Technical challenges282

Limitations of proteomics283

Limitations of 2DGE283

Limitations of mass spectrometry techniques283

Complexity of the pharmaceutical proteomics283

Unmet needs in proteomics284

9.Future of Proteomics285

Genomics to proteomics285

Faster technologies285

FLEXGene repository285

Need for new proteomic technologies286

Emerging proteomic technologies287

Detection of alternative protein isoforms287

Direct protein identification in large genomes by mass spectrometry287

Proteome identification kits with stacked membranes287

Vacuum deposition interface288

In vitro protein biosynthesis288

Proteome mining with adenosine triphosphate288

Proteome-scale purification of human proteins from bacteria288

Proteostasis network289

Cytoproteomics289

Subcellular proteomics289

Individual cell proteomics290

Live cell proteomics290

Fluorescent proteins for live-cell imaging291

Membrane proteomics291

Identification of membrane proteins by tandem MS of protein ions291

Solid state NMR for study of nanocrystalline membrane proteins292

Multiplex proteomics292

High-throughput for proteomics292

Future directions for protein biochip application293

Bioinformatics for proteomics293

High-Throughput Crystallography Consortium293

Study of protein folding by IBM's Blue Gene294

Study of proteins by atomic force microscopy294

Population proteomics294

Comparative proteome analysis295

Human Proteome Organization295

Human Salivary Proteome296

Academic-commercial collaborations in proteomics296


'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Reportlinker Adds Biotechnology Pharmaceutical Market in US -2013
2. Reportlinker Adds US Vaccines Market
3. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
4. Reportlinker Adds Womens Infertility - Pipeline Assessment and Market Forecasts to 2017
5. Reportlinker Adds Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
6. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
7. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
8. Reportlinker Adds Protein Kinase Therapeutics in Oncology - Where to Commercialize?
9. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
10. Reportlinker Adds Advances in Biopharmaceutical Technology in China
11. Reportlinker Adds Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 The ... (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & ... and studies the Major Market Drivers, Restraints, and Opportunities in ... , Asia-Pacific and Rest of World. ... Tables 22 Figures ...
(Date:6/18/2013)... 2013 Research and ... addition of the "Injectable Drug Delivery ... Devices [Disposables & Reusable, Fillable & Prefilled, ... Therapeutics [Diabetes & Oncology] - Global Forecasts ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ...
(Date:6/18/2013)... Inflamax Research Inc., a full service ... I-IV clinical trials, announced today that they will ... Technologies (NAET), a specialty air conditioning & environmental ... of mobile Environmental Exposure Chambers (EECs) used in ... , Inflamax Research has proprietary Next Generation ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 On June ... (CMS) released a final decision memorandum concluding that ... guide subsequent management of anti-tumor strategy, and the ... The National Oncological PET Registry (NOPR) was developed jointly ... first projects under the Coverage with Evidence Development (CED) ...
Breaking Biology Technology:Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 2Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3
... Mo., Nov. 7 In refusing to a ... removal and replacement of its,current directors, management of ... developer and manufacturer of diagnostic products whose,American Depository ... that the preservation of their jobs and positions ...
... is an observational study undertaken to evaluate the, ... freezing) techniques, ROCKLAND, Mass., Nov. 7 /PRNewswire/-- ... Darmstadt, Germany, announced the launch of the Human,Oocyte ... Meeting of the American Society for Reproductive Medicine ...
... Calif., Nov. 7 AutoImmune Inc. (OTC,Bulletin Board: AIMM) today ... basic and diluted, for the three months ended September 30, ... per share basic and,diluted, for the three months ended September ... net loss was $216,000, or $0.01 per share,basic and diluted, ...
Cached Biology Technology:Trinity Biotech Management Refuses to Honor Call for a Special Meeting of Shareholders 2Trinity Biotech Management Refuses to Honor Call for a Special Meeting of Shareholders 3EMD Serono Launches Landmark Patient Registry for Egg Freezing 2EMD Serono Launches Landmark Patient Registry for Egg Freezing 3EMD Serono Launches Landmark Patient Registry for Egg Freezing 4AutoImmune Inc. Reports 2008 Third Quarter Financial Results 2AutoImmune Inc. Reports 2008 Third Quarter Financial Results 3
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
(Date:6/18/2013)... and 10% of breast and ovarian cancers are familial ... are attributable to inherited mutations from the parents in ... these mutations, PARP inhibitors, which are currently in clinical ... new option for personalised cancer treatment, an alternative to ... fraction of these patients generate resistance to the drug ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
... the sun's heat on weather balloons largely accounts for ... dispute over the existence of global warming, according to ... National Oceanic and Atmospheric Administration (NOAA). , The report, ... direct heat of the sun on temperature probes of ...
... times and until our very own day, been considered ... every growing thing in their path. , Until now, ... were predominantly directed by prevailing winds. Now, Hebrew University ... of these grasshoppers ?namely their polarization vision -- provides ...
... Alberta research team has discovered important new information they ... arterial hypertension (PAH)--a deadly form of high blood pressure ... Therapies are currently limited for a disease that can ... years. , The researchers have shown that Survivin, a ...
Cached Biology News:Errors in the measurement of global warming corrected 2Locusts' built-in 'surface analysis' ability directs them to fly overland 2Researchers develop gene therapy to reverse pulmonary arterial hypertension 2Researchers develop gene therapy to reverse pulmonary arterial hypertension 3
Blue Standard is 3-cyano-7-hydroxycoumarin....
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
6-(2,4-dinitrophenyl)aminohexanoic acid, succinimidyl ester (DNP-X, SE)...
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: